A practical reference on research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-07-29. Anything still debated is marked as such rather than presented as settled.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
28 November – In a letter to MPs, the Chairman of the Office for Budget Responsibility casts doubt on the Chancellor's pre-Budget statements about the state of the UK economy. Reeves had spoken of a downgrade in economic forecasts that would make it difficult to meet her spending rules, but the letter says an increase in wages would have made it possible. 29 November – The Your Party founding conference begins, but after several party members who also belong to the Socialist Workers Party are expelled, Zarah Sultana boycotts the event and accuses the party's leadership of staging a "witch hunt" against left-wing activists. 30 November – On the second day of its founding conference, Your Party adopts the name Your Party as its official name.
Action – Uncharted 2: Among Thieves Artistic Achievement – Flower Best Game – Batman: Arkham Asylum Family & Social – Wii Sports Resort Gameplay – Batman: Arkham Asylum Handheld – LittleBigPlanet Multiplayer – Left 4 Dead 2 Original Score – Uncharted 2: Among Thieves Sports – FIFA 10 Story – Uncharted 2: Among Thieves Strategy – Empire: Total War Use of Audio – Uncharted 2: Among Thieves Use of Online – FIFA 10 BAFTA One's to Watch Award (in association with Dare to Be Digital) – Shrunk! GAME Award of 2009 – Call of Duty: Modern Warfare 2 Academy Fellowship – Shigeru Miyamoto
The 1995 season was shortened by 18 games due to the players' strike that commenced the year before. Bagwell endured a slump through the month of May in which he batted .183. In June, his results started to improve as he batted .339 and followed up in July by driving in 31 runs. Both Bagwell and Derek Bell, included as a "Killer B," registered 31 RBI that month, breaking the monthly club RBI record. Bagwell had tied the previous record one year earlier to the month. He hit his first two career home runs against Maddux of the Atlanta Braves within a week, on May 28 and June 3. Maddux allowed only 8 home runs the entire season. On July 28 against the Colorado Rockies, Bagwell's 10th-inning home run tied the score and two innings later he scored the winning run for a 5–4 final score. For the third time in three seasons, an incoming pitch broke a bone in Bagwell's left hand: on this occasion, it was on July 30 from the Padres' Brian Williams. Rather than change his successful style, Bagwell resorted to wearing a heavily padded protective batting glove. He returned in September to bat .313 with five home runs and 21 RBI as Houston finished one game behind the Rockies for the NL wild card. Bagwell missed 30 games, appearing in 114 and batted .290 with 21 home runs. He won the 1995 ESPY Awards for Best Breakthrough Athlete and Outstanding Baseball Performer (later renamed "Best Major League Baseball Player"). After the season, he commenced a rigorous training program that enabled him to gain 20 pounds and increased his endurance for the long season.
Sources: en.wikipedia.org
Hindu-Arabic numerals were not originally designed to indicate their numeric value through the number of angles they contain. There are no historical records of this, and the myth is difficult to reconcile with digits past 3 or 4. The Greek philosopher Pythagoras was not the first to discover what is now called the Pythagorean theorem, as it was known and used by the Babylonians and Indians centuries before him. Pythagoras may have been the first to introduce it to the Greeks, but the first record of it being mathematically proven as a theorem is in Euclid's Elements which was published some 200 years after Pythagoras. There is no evidence that the ancient Greeks deliberately designed the Parthenon to match the golden ratio. The Parthenon was completed in 438 BCE, more than a century before the first recorded mention of the ratio by Euclid. Similarly, Leonardo da Vinci's Vitruvian Man makes no mention of the golden ratio in its text, although it describes many other proportions. The repeating decimal written as 0.999... represents exactly the same quantity as 1. The p-value is not the probability that the null hypothesis is true, or the probability that the alternative hypothesis is false; it is the probability of obtaining results at least as extreme as the results actually observed under the assumption that the null hypothesis was correct, which can indicate the incompatibility of results with the specific statistical model assumed in the null hypothesis. This misconception, and similar ones like it, contributes to the common misuse of p-values in education and research.
Regarding the last quarter-century of the period outlined by Taylor, his American colleague, diplomatic historian Edward Mead Earle, argued: "During the quarter-century beginning about 1890, Europe and the Far East lived under a precarious balance of power with the result … that the world moved crazily from one crisis to another and finally to catastrophe". Earle concludes: "The balance of power may well land us all in crematory". The balance of power theory prepared catastrophe in 1939 as in 1914, wrote Clarence Streit in his famous Union Now. There is "no more sterile, illusory, fantastic, exploded and explosive peace policy than the balance of power." In 1953, Ernst B. Haas criticized balance of power theory, arguing that international relations works that used the concept were plagued with "philological, semantic, and theoretical confusion." Since 1945, the arguments of Streit and Earle has prevailed over that of Taylor. Atomic scientists launched an all-out attack on the balance-of-power concept:
In castrated immature male rats, vosilasarm (at 10 mg/kg/day orally, the highest assessed dose) maximally stimulated prostate weight to 67%, seminal vesicle weight to 59%, and levator ani muscle weight to 117% compared to that induced with testosterone propionate 1 mg/kg/day. Moreover, when combined with testosterone propionate, vosilasarm partially antagonized the weight increases of the prostate gland and seminal vesicles, reducing them to 84% and 78% (both from 100%), respectively. Conversely however, the combination of testosterone propionate and vosilasarm was additive in terms of levator ani muscle weight stimulation, increasing it to 124%. Vosilasarm was found to stimulate muscle at a dose much lower than that required to stimulate the prostate. A dose of 0.3 mg/kg/day stimulated levator ani muscle weight to a similar extent relative to the levator ani weight in non-castrated controls. Conversely, a 33-fold higher dose of 10 mg/kg/day was required to stimulate prostate weight to a similar extent as that in non-castrated controls. Similarly, in gonadally intact immature rats, 0.3 mg/kg/day vosilasarm stimulated levator ani muscle weight to a similar extent as testosterone propionate 0.5 mg/kg/day, but a dose of 30 mg/kg/day (100-fold higher) was required to stimulate the prostate to a similar extent as testosterone propionate 0.5 mg/kg/day.
Aperture Desk Job is a free game set in the Portal universe released on March 1, 2022. It is a demonstration of the various features of the Steam Deck handheld system. In the game, the player works as a quality assurance checker for toilets manufactured by Aperture Science in its early years. They are guided by the personality core Grady through the steps, but as the game progresses, mishaps in the automated factory lead Grady to suggest that the player develop a weaponized toilet as an invention to pitch to Cave Johnson.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
The lyophilized powder is commonly kept at -20 °C or lower, protected from moisture and light. Solutions may require colder storage and should avoid repeated freeze-thaw cycles. General peptide stability practices apply.